Neuroleptic drugs and the dopamine hypothesis.
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D006719:Homovanillic Acid / Q000378:metabolism; D006801:Humans; D008032:Limbic System / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects* / Q000378:metabolism; D012559:Schizophrenia / Q000378:metabolism; D013881:Thioridazine / Q000494:pharmacology*; D014268:Trifluoperazine / Q000494:pharmacology*
D011954:Receptors, Dopamine; D015102:3,4-Dihydroxyphenylacetic Acid; D014268:Trifluoperazine; D013881:Thioridazine; D004298:Dopamine; D006719:Homovanillic Acid